CCMG
GILD icon

Clark Capital Management Group’s Gilead Sciences GILD Stock Holding History

Clark Capital Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50M Buy
395,783
+394,109
+23,543% +$51.9M 0.27% 117
2026
Q1 		$233K Buy
+1,674
New +$234K ﹤0.01% 488
2016
Q2 		– Sell
-162,810
Closed -$15M – 313
2016
Q1 		$15M Buy
162,810
+23,251
+17% +$2.1M 1.16% 22
2015
Q4 		$14.1M Buy
139,559
+718
+0.5% +$74.7K 1.15% 14
2015
Q3 		$13.6M Buy
138,841
+4,518
+3% +$502K 1.22% 8
2015
Q2 		$15.7M Buy
134,323
+48,769
+57% +$5.33M 1.44% 9
2015
Q1 		$8.39M Buy
85,554
+58,369
+215% +$5.93M 0.76% 38
2014
Q4 		$2.56M Buy
27,185
+698
+3% +$72.2K 0.23% 90
2014
Q3 		$2.82M Buy
26,487
+5,592
+27% +$548K 0.24% 81
2014
Q2 		$1.73M Buy
20,895
+11,918
+133% +$928K 0.14% 109
2014
Q1 		$636K Sell
8,977
-400
-4% -$31.4K 0.05% 167
2013
Q4 		$704K Buy
9,377
+133
+1% +$9.26K 0.06% 156
2013
Q3 		$581K Buy
9,244
+488
+6% +$29.2K 0.05% 169
2013
Q2 		$449K Buy
+8,756
New +$456K 0.04% 195

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clark Capital Management Group's GILD Position: Q2 2026 in Review

Clark Capital Management Group increased its Gilead Sciences (GILD) stake by 23,543% in Q2 2026, buying an estimated $51.9M and bringing the position to 395,783 shares worth $50M. The position accounts for 0.27% of the portfolio, ranked #117.

Clark Capital Management Group first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Clark Capital Management Group held 395,783 shares of Gilead Sciences worth $50M as of Q2 2026.
  • Clark Capital Management Group bought 394,109 Gilead Sciences shares in Q2 2026, an estimated $51.9M.
  • Gilead Sciences made up 0.27% of Clark Capital Management Group's portfolio in Q2 2026, its #117 holding.
  • Clark Capital Management Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Clark Capital Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.